NCT03346954View on ClinicalTrials.gov

Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

June 11, 2019

Study Completion Date

August 31, 2020

Conditions
Cushing's Disease
Interventions
OTHER

[11C]-Methionine PET/MRI

Implementation \[11C\]-Methionine PET/MRI performed for each patient in one place (department of nuclear medicine of the Hospices Civils de Lyon). The \[11C\]-Methionine PET/MRI will be performed after a pituitary MRI and before a transsphenoidal surgery.

Trial Locations (1)

69677

Service de Médecine Nucléaire - Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03346954 - Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease | Biotech Hunter | Biotech Hunter